Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 40kWORD 18k
18 January 2019
Question for written answer E-000239-19
to the Commission
Rule 130
Louis Michel (ALDE)

 Subject:  Non-alcoholic steatohepatitis
 Answer in writing 

Over the past few years, many people in Europe have developed non-alcoholic steatohepatitis (NASH), also known as the ‘soft-drinks disease’. We consume junk food and soft drinks on a daily basis, and the sugar in our diet causes fat to accumulate in the liver. The number of people with diabetes and obesity is constantly increasing. Processed foods are high in additives and regular consumption of these foods can result in cirrhosis (impaired liver function), or even liver cancer, a disease which not only affects adults, but also young children.

The EU-funded ‘fatty liver: inhibition of progression’ (FLIP) project aims to understand and prevent the progression of the disease. Yet very few people know about the project, or are even aware of being exposed to a health risk of this kind.

Should the Commission not therefore be publicising NASH and the FLIP project more effectively in the Member States in order to make EU citizens aware of this public health problem?

Similarly, will it take action to reduce the amount of additives and sugar in processed foods and drinks?

Original language of question: FR 
Last updated: 11 February 2019Legal notice